Edwards Lifesciences Price to Sales Ratio 2011-2025 | EW
Historical PS ratio values for Edwards Lifesciences (EW) over the last 10 years. The current P/S ratio for Edwards Lifesciences as of November 18, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Edwards Lifesciences P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-11-18 | 84.04 | 8.43 | |
| 2025-09-30 | 77.77 | $9.97 | 7.80 |
| 2025-06-30 | 78.21 | $9.59 | 8.16 |
| 2025-03-31 | 72.48 | $9.25 | 7.84 |
| 2024-12-31 | 74.03 | $9.04 | 8.19 |
| 2024-09-30 | 65.99 | $8.39 | 7.86 |
| 2024-06-30 | 92.37 | $8.17 | 11.31 |
| 2024-03-31 | 95.56 | $8.02 | 11.91 |
| 2023-12-31 | 76.25 | $8.21 | 9.29 |
| 2023-09-30 | 69.28 | $7.24 | 9.57 |
| 2023-06-30 | 94.33 | $7.31 | 12.90 |
| 2023-03-31 | 82.73 | $7.38 | 11.21 |
| 2022-12-31 | 74.61 | $7.12 | 10.47 |
| 2022-09-30 | 82.63 | $8.54 | 9.67 |
| 2022-06-30 | 95.09 | $8.50 | 11.18 |
| 2022-03-31 | 117.72 | $8.50 | 13.86 |
| 2021-12-31 | 129.55 | $8.29 | 15.62 |
| 2021-09-30 | 113.21 | $8.07 | 14.03 |
| 2021-06-30 | 103.57 | $7.81 | 13.27 |
| 2021-03-31 | 83.64 | $7.11 | 11.76 |
| 2020-12-31 | 91.23 | $6.96 | 13.10 |
| 2020-09-30 | 79.82 | $6.92 | 11.53 |
| 2020-06-30 | 69.11 | $6.83 | 10.12 |
| 2020-03-31 | 62.87 | $7.05 | 8.92 |
| 2019-12-31 | 77.76 | $6.83 | 11.38 |
| 2019-09-30 | 73.30 | $6.51 | 11.25 |
| 2019-06-30 | 61.58 | $6.21 | 9.91 |
| 2019-03-31 | 63.78 | $5.97 | 10.68 |
| 2018-12-31 | 51.06 | $5.80 | 8.80 |
| 2018-09-30 | 58.03 | $5.65 | 10.28 |
| 2018-06-30 | 48.52 | $5.49 | 8.83 |
| 2018-03-31 | 46.51 | $5.33 | 8.73 |
| 2017-12-31 | 37.57 | $5.30 | 7.09 |
| 2017-09-30 | 36.44 | $5.10 | 7.14 |
| 2017-06-30 | 39.41 | $4.97 | 7.94 |
| 2017-03-31 | 31.36 | $4.83 | 6.49 |
| 2016-12-31 | 31.23 | $4.54 | 6.88 |
| 2016-09-30 | 40.19 | $4.38 | 9.18 |
| 2016-06-30 | 33.24 | $4.18 | 7.95 |
| 2016-03-31 | 29.40 | $3.95 | 7.44 |
| 2015-12-31 | 26.33 | $3.78 | 6.97 |
| 2015-09-30 | 23.70 | $3.71 | 6.39 |
| 2015-06-30 | 23.74 | $3.71 | 6.40 |
| 2015-03-31 | 23.74 | $3.67 | 6.47 |
| 2014-12-31 | 21.23 | $3.58 | 5.93 |
| 2014-09-30 | 17.03 | $3.41 | 4.99 |
| 2014-06-30 | 14.31 | $3.21 | 4.45 |
| 2014-03-31 | 12.36 | $3.07 | 4.03 |
| 2013-12-31 | 10.96 | $2.98 | 3.68 |
| 2013-09-30 | 11.61 | $2.91 | 3.98 |
| 2013-06-30 | 11.20 | $2.81 | 3.99 |
| 2013-03-31 | 13.69 | $2.74 | 5.01 |
| 2012-12-31 | 15.03 | $2.67 | 5.62 |
| 2012-09-30 | 17.90 | $2.55 | 7.00 |
| 2012-06-30 | 17.22 | $2.51 | 6.87 |
| 2012-03-31 | 12.12 | $2.43 | 5.00 |
| 2011-12-31 | 11.78 | $2.34 | 5.04 |
| 2011-09-30 | 11.88 | $2.29 | 5.20 |
| 2011-06-30 | 14.53 | $2.20 | 6.62 |
| 2011-03-31 | 14.50 | $2.11 | 6.87 |
| 2010-12-31 | 13.47 | $2.03 | 6.65 |
| 2010-09-30 | 11.18 | $1.97 | 5.67 |
| 2010-06-30 | 9.34 | $1.94 | 4.81 |
| 2010-03-31 | 8.24 | $1.91 | 4.32 |
| 2009-12-31 | 7.24 | $1.88 | 3.85 |
| 2009-09-30 | 5.83 | $1.82 | 3.20 |
| 2009-06-30 | 5.67 | $1.79 | 3.17 |
| 2009-03-31 | 5.05 | $1.76 | 2.87 |
| 2008-12-31 | 4.58 | $1.74 | 2.63 |
| 2008-09-30 | 4.81 | $1.69 | 2.84 |
| 2008-06-30 | 5.17 | $1.61 | 3.20 |
| 2008-03-31 | 3.71 | $1.52 | 2.44 |
| 2007-12-31 | 3.83 | $1.45 | 2.65 |
| 2007-09-30 | 4.11 | $1.40 | 2.93 |
| 2007-06-30 | 4.11 | $1.38 | 2.98 |
| 2007-03-31 | 4.23 | $1.36 | 3.10 |
| 2006-12-31 | 3.92 | $1.35 | 2.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $49.175B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.087B | 25.32 |
| Intuitive Surgical (ISRG) | United States | $195.983B | 76.68 |
| IDEXX Laboratories (IDXX) | United States | $53.421B | 53.05 |
| Alcon (ALC) | Switzerland | $37.787B | 25.54 |
| IQVIA Holdings (IQV) | United States | $36.805B | 20.52 |
| Mettler-Toledo (MTD) | United States | $28.374B | 33.20 |
| STERIS (STE) | Ireland | $25.225B | 26.04 |
| DexCom (DXCM) | United States | $22.812B | 31.45 |
| Waters (WAT) | United States | $22.503B | 29.76 |
| Hologic (HOLX) | United States | $16.490B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.802B | 0.00 |
| Globus Medical (GMED) | United States | $11.194B | 23.49 |
| Penumbra (PEN) | United States | $10.907B | 76.72 |
| Masimo (MASI) | United States | $7.898B | 25.31 |
| Sysmex ADR (SSMXY) | Japan | $6.137B | 19.50 |
| Glaukos (GKOS) | United States | $5.077B | 0.00 |
| Teleflex (TFX) | United States | $4.590B | 7.31 |
| TransMedics (TMDX) | United States | $3.875B | 45.91 |
| Veracyte (VCYT) | United States | $3.105B | 35.39 |
| Alphatec Holdings (ATEC) | United States | $2.952B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.929B | 15.82 |
| Integer Holdings (ITGR) | United States | $2.351B | 11.04 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| Nihon Kohden (NHNKY) | Japan | $1.794B | 15.66 |
| Elekta AB (EKTAY) | Sweden | $1.692B | 16.39 |
| PROCEPT BioRobotics (PRCT) | United States | $1.625B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.243B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.196B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.087B | 51.77 |
| OPKO Health (OPK) | United States | $0.975B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.932B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.914B | 4.95 |
| SiBone (SIBN) | United States | $0.778B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.570B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.524B | 30.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.516B | 10.30 |
| AngioDynamics (ANGO) | United States | $0.491B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.474B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.409B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.396B | 10.92 |
| Sight Sciences (SGHT) | United States | $0.372B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.323B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.65 |
| Semler Scientific (SMLR) | United States | $0.304B | 2.29 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.184B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.182B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.118B | 0.00 |
| Neuronetics (STIM) | United States | $0.113B | 0.00 |
| Accuray (ARAY) | United States | $0.113B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.091B | 0.00 |
| Hyperfine (HYPR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.066B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.07 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |